SciClone Pharmaceuticals

Quick facts

Phase 3 pipeline

• placebo + PEGinterferon alfa-2a · Immunology
  PEGinterferon alfa-2a is an immunomodulatory agent that enhances antiviral and anti-tumor immune responses by activating interferon signaling pathways.
• thymalfasin (thymosin alpha 1) · Immunology
  Thymalfasin (thymosin alpha 1) is a peptide that stimulates the immune system by activating T cells and natural killer cells.

Phase 2 pipeline

• Chemotherapy Prednisone
• SCV-07

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• SciClone Pharmaceuticals portfolio CI brief
• SciClone Pharmaceuticals pipeline updates RSS